Join
Live feed
·
INSIDERFilingvia Quantisnow
Alexion Pharmaceuticals, Inc. logo

SEC Form 4: Bazarko Daniel was granted 21,708 units of Common Stock, increasing direct ownership by 56% to 60,207 units

ByQuantisnow·Wall Street's wire, on your screen.
ALXN· Alexion Pharmaceuticals, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALXN (Alexion Pharmaceuticals, Inc.) and more on Quantisnow.